IMMUNIC INC (IMUX) Forecast, Price Target & Analyst Ratings

NASDAQ:IMUX • US4525EP1011

Current stock price

1.06 USD
-0.05 (-4.5%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for IMMUNIC INC (IMUX).

Forecast Snapshot

Consensus Price Target

Price Target
$5.36
+ 405.19% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 13, 2026
Period
Q1 / 2026
EPS Estimate
-$0.09
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
86.67%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$5.36
Upside
+ 405.19%
From current price of $1.06 to mean target of $5.36, Based on 15 analyst forecasts
Low
$3.03
Median
$4.59
High
$10.50

Price Target Revisions

1 Month
7.69%
3 Months
-2.33%

Price Target Summary

15 Wall Street analysts provided a forecast for the next 12 months for IMUX. The average price target is 5.36 USD. This implies a price increase of 405.19% is expected in the next year compared to the current price of 1.06.
The average price target has been revised downward by 2.33% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

IMUX Current Analyst RatingIMUX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6

Analyst Ratings History

IMUX Historical Analyst RatingsIMUX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10

Analyst Ratings Consensus

ChartMill Buy Consensus
86.67%
IMUX was analyzed by 15 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about IMUX.
In the previous month the buy percentage consensus was at a similar level.
IMUX was analyzed by 15 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-04-15D. Boral CapitalDowngrade Buy -> Hold
2026-03-24GuggenheimInitiate Buy
2026-03-02HC Wainwright & Co.Maintains Buy -> Buy
2026-02-13D. Boral CapitalMaintains Buy -> Buy
2026-02-09HC Wainwright & Co.Reiterate Buy -> Buy
2026-01-07D. Boral CapitalMaintains Buy -> Buy
2025-11-14HC Wainwright & Co.Maintains Buy -> Buy
2025-11-13D. Boral CapitalMaintains Buy -> Buy
2025-09-29Chardan CapitalInitiate Buy
2025-09-26HC Wainwright & Co.Reiterate Buy -> Buy
2025-09-25D. Boral CapitalMaintains Buy -> Buy
2025-08-08D. Boral CapitalMaintains Buy -> Buy
2025-06-25D. Boral CapitalMaintains Buy -> Buy
2025-06-05D. Boral CapitalMaintains Buy -> Buy
2025-05-29D. Boral CapitalMaintains Buy -> Buy
2025-05-23B. Riley SecuritiesReiterate Buy -> Buy
2025-05-01HC Wainwright & Co.Reiterate Buy -> Buy
2025-04-30D. Boral CapitalMaintains Buy -> Buy
2025-04-16B. Riley SecuritiesReiterate Buy -> Buy
2025-04-15HC Wainwright & Co.Reiterate Buy -> Buy
2025-04-10D. Boral CapitalMaintains Buy -> Buy
2025-04-01D. Boral CapitalMaintains Buy -> Buy
2025-03-25William BlairInitiate Outperform
2025-02-26D. Boral CapitalMaintains Buy -> Buy
2025-02-21HC Wainwright & Co.Reiterate Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 13, 2026
Period
Q1 / 2026
EPS Estimate
-$0.09
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
63.79%
Number of Analysts
11

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
3.19%
EPS (3 Months)
5.76%

Next Earnings Summary

IMUX is expected to report earnings on 5/13/2026. The consensus EPS estimate for the next earnings is -0.09 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
IMUX revenue by date.IMUX revenue by date.
N/AN/AN/A
1,337.98%		N/A
246.25%		N/A
83.17%		N/A
57.42%		N/A
49.18%		N/A
10.50%
EBITDA
YoY % growth
IMUX ebitda by date.IMUX ebitda by date.
-50.79M-39.46M
22.31%		-51.66M
-30.92%		-37.68M
27.06%		-36.98M
1.86%		-48.93M
-32.31%		-74.33M
-51.91%		-86.44M
-16.29%		-99.112M
-14.66%		-97.918M
1.20%		-103.06M
-5.25%		N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
IMUX ebit by date.IMUX ebit by date.
-52.12M-41.27M
20.82%		-52.66M
-27.60%		-38.41M
27.06%		-37.03M
3.59%		-48.97M
-32.24%		-74.42M
-51.97%		-86.52M
-16.26%		-99.223M
-14.68%		-98.052M
1.18%		-103.228M
-5.28%		N/A
-13.78%		N/A
-5.02%		N/A
139.00%		N/A
185.88%		N/A
310.23%		N/A
97.10%		N/A
121.94%		N/A
21.39%
Operating Margin
IMUX operating margin by date.IMUX operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
IMUX eps by date.IMUX eps by date.
-84.00-52.00
38.10%		-53.20
-2.31%		N/AN/A-2.85
20.17%		-3.93
-37.89%		-3.77
4.07%		-2.11
44.03%		-1.00
52.61%		-0.65
35.00%		N/A
42.13%		N/A
16.32%		N/A
49.44%		N/A
136.35%		N/A
1,425.57%		N/A
-42.20%		N/A
74.00%		N/A
48.28%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-0.09
63.79%		-0.09
53.46%		-0.10
25.46%		-0.10
-43.89%		-0.11
-18.31%		-0.11
-20.55%		-0.12
-21.05%		-0.12
-16.46%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-26.973M
-0.55%		-28.867M
-6.59%		-30.648M
-17.91%		-33.502M
-43.62%		-39.427M
-46.17%		-42.481M
-47.16%		-45.778M
-49.37%		-49.338M
-47.27%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

IMUX Yearly Revenue VS EstimatesIMUX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2027 2028 2029 2030 2031 2032 2033 1B 2B 3B
IMUX Yearly EPS VS EstimatesIMUX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -20 -40 -60 -80

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
20.63%
EPS Next 5 Year
27.41%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

IMMUNIC INC / IMUX Forecast FAQ

What do analysts expect the price target to be for IMMUNIC INC (IMUX)?

15 analysts have analysed IMUX and the average price target is 5.36 USD. This implies a price increase of 405.19% is expected in the next year compared to the current price of 1.06.

When does IMMUNIC INC (IMUX) report earnings?

IMMUNIC INC (IMUX) will report earnings on 2026-05-13, before the market open.

What are the consensus estimates for IMUX stock next earnings?

The consensus EPS estimate for the next earnings of IMMUNIC INC (IMUX) is -0.09 USD and the consensus revenue estimate is 0 USD.

What is the consensus rating for IMMUNIC INC (IMUX) stock?

The consensus rating for IMMUNIC INC (IMUX) is 86.6667 / 100 . This indicates that analysts generally have a positive outlook on the stock.